New investing trends frequently emerge on Wall Street, but dividend investing remains consistently appealing due to the stability and potential for long-term returns it offers. Currently, Pfizer (NYSE: PFE) and AbbVie (NYSE: ABBV) are highlighted as attractive dividend stocks. Although Pfizer’s financial results have been inconsistent, the company is revitalizing its pipeline with promising products like PF-4044, an investigational cancer drug aimed at competing with Keytruda.
Want More Context? 🔎
Loading PerspectiveSplit analysis...
